Los Angeles, California, United States The venture was found in North America in United States. The main office of represented VC is situated in the Los Angeles.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Coastview Capital, startups are often financed by Sanderling Ventures, RCT BioVentures, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Flagship Pioneering, William Harris Investors. In the next rounds fund is usually obtained by Lilly Ventures, HBM Healthcare Investments AG, Bioventures Investors.
Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Coastview Capital performs on 38 percentage points more the average number of lead investments. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2010. The top activity for fund was in 2005. The common things for fund are deals in the range of 10 - 50 millions dollars.
Among the most popular portfolio startups of the fund, we may highlight Cylene Pharmaceuticals, Hypnion, CGI Pharmaceuticals. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Medical. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
Related Funds
Funds with similar focus
| Fund Name | Location |
| adMare Bio Innovations | British Columbia, Canada, Vancouver |
| Aspen Capital Group | - |
| Edelweiss Tokio Life Insurance | India, Maharashtra, Mumbai |
| Invesco | Atlanta, Georgia, United States |
| IQbility | Attiki, Greece, Kallithéa |
| Kokopelli Capital | - |
| Nanshan Venture Capital | China, Guangdong, Shenzhen |
| Origin Capital | Dublin, Dublin, Ireland |
| Pointbreak | Khomas, Namibia, Windhoek |
| Poland Prize Program | - |
| Purple Cow | Brentwood, California, United States |
| SMS Capital Management | Bellaire, Texas, United States |
| Soros Fund Management | New York, New York, United States |
| Stone Street Partners | Charlotte, North Carolina, United States |
| The Ohio State University | Columbus, Ohio, United States |
| Ticonderoga Capital | Braintree, Massachusetts, United States |
| Tongjian Tailite | Beijing, Beijing, China |
| Transition Capital Partners | Dallas, Texas, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cylene Pharmaceuticals | $26M | 26 May 2005 | San Diego, California, United States | ||
CGI Pharmaceuticals | $22M | 21 Jan 2004 | Branford, Connecticut, United States | ||
Hypnion | $47M | 17 Mar 2003 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cylene Pharmaceuticals | $26M | 26 May 2005 | San Diego, California, United States | ||
CGI Pharmaceuticals | $22M | 21 Jan 2004 | Branford, Connecticut, United States | ||
Hypnion | $47M | 17 Mar 2003 | Massachusetts, United States |
